381% multibagger returns: Debt-free penny stock under Rs 50 hit 52-week high; Trades at triple-digit ROE
DSIJ Intelligence-1 / 25 Nov 2025/ Categories: Multibaggers, Penny Stocks, Trending

Technical indicators are highly bullish: the share price is at a 1-year peak, supported by the highest trading volumes seen in recent sessions, and is trading well above 50-DMA and 200-DMA.
On Tuesday, shares of Take Solutions Ltd surged 3.33 per cent and hit a 52-week high of Rs 31.30 per share from its previous closing of Rs 30.29 per share. The stock has given multibagger returns of 381 per cent from its 52-week low of Rs 6.51 per share. Technical indicators are highly bullish: the share price is at a 1-year peak, supported by the highest trading volumes seen in recent sessions, and is trading well above 50-DMA and 200-DMA. The stock has an all-time high of Rs 297.65 per share.
Incorporated in 2000, TAKE Solutions Ltd is a technology-driven company primarily focused on the Life Sciences and Supply Chain Management sectors. Its core business centres on providing comprehensive services for clinical development, including managing clinical trials, offering generics support such as bio-availability and bioequivalent studies, and handling critical regulatory functions like regulatory filing and pharmacovigilance. While providing end-to-end services in Life Sciences, the company also offers specific offerings in supply chain management, utilising an Intellectual Property-led approach to help clients optimise their supply chain processes, automate operations, and ensure compliance. This specialised focus positions TAKE Solutions as a domain-intensive service provider in its key markets.
The company has a market cap of over Rs 450 crore and has delivered good profit growth of 38.1 per cent CAGR over the last 5 years. In FY25, the company reported a total income of Rs 10.22 crore and a net profit of Rs 37.48 crore. As of September 2025, the company is debt-free and the stock traded at a triple-digit ROE of 644 per cent with a PE of 113x.
Disclaimer: The article is for informational purposes only and not investment advice.